← Back to Clinical Trials
Recruiting NCT06673849

NCT06673849 Rhythmic Stabilization Versus Ball Balancing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06673849
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Spastic Cerebral Palsy (sCP)
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2024-09-25
Primary Completion 2024-12-02

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Rhythmic StabilizationBall Balancing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2024-09-25 with a primary completion date of 2024-12-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Spastic Cerebral Palsy (CP) is the leading cause of upper motor neuron syndrome (UMN) in children. The primary factors contributing to motor behavior disorders in these children are impairments in motor control and muscle strength. These impairments result in changes in muscle growth and hinder the development of motor skills, leading to reduced muscle force generation and decreased flexibility. Spastic cerebral palsy is the most prevalent type, affecting 77% of individuals with CP, and is caused by damage to the motor cortex and pyramidal tracts. The motor cortex is responsible for transmitting voluntary movement signals from the brain to the muscles. Characteristics of spastic cerebral palsy include stiff muscles (hypertonia), which can cause jerky and repetitive limb movements (spasticity). Additionally, individuals with CP often have difficulties in processing somatosensory and proprioceptive information. Proprioceptive training refers to interventions aimed at enhancing proprioceptive function to ultimately improve motor performance, a concept that has been explored in studies focused on sports injuries. In this study, we will utilize two proprioceptive exercises-rhythmic stabilization and ball balancing-to promote functional improvement in the upper extremities of children with spastic CP.

Eligibility Criteria

Inclusion Criteria: * Spastic diplegic CP children age 6 to 12 years, * Each gender included * Grade 1 of spasticity according to modified Ashworth scale (21) * With normal I.Q. greater than 70 (assessed by psychologist), * Can follow commands( Exclusion Criteria: * Children with any other neurological impairment * Children with audio visual impairment

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ Imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Masifah Kashif, MS*

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06673849 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Spastic Cerebral Palsy (sCP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06673849 currently recruiting?

Yes, NCT06673849 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06673849 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06673849 clinical trial?

NCT06673849 is sponsored by Riphah International University. The principal investigator is Masifah Kashif, MS* at Riphah International University. The trial plans to enroll 36 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology